Robert J. de Vaere Attorney-In-Fact Net Worth & Insider Trades
Robert J. de Vaere Attorney-In-Fact - EVP & Chief Business Officer, Horizon Pharma Plc
What is Robert J. de Vaere Attorney-In-Fact's Net Worth?
The current estimated net worth of Horizon Pharma Plc's EVP & Chief Business Officer, Robert J. de Vaere Attorney-In-Fact, is estimated to be about $2.41M . Robert J. de Vaere Attorney-In-Fact owns about 88,555 units of Horizon Pharma Plc common stock. In the last 3 years at Horizon Pharma Plc, Robert J. de Vaere Attorney-In-Fact has sold an estimated value of $215.91K worth.
What is Robert J. de Vaere Attorney-In-Fact's Past Insider Trading?
Robert J. de Vaere Attorney-In-Fact's largest sale order was 12,939 units , worth over $167.43K on May 21, 2014. In total, Robert J. de Vaere Attorney-In-Fact has made about 10 transactions over 3 years of their time at Horizon Pharma Plc. Robert J. de Vaere Attorney-In-Fact usually trades in September, January, March and December, with the busiest year in 2014.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Robert Carey
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |
InsideArbitrage
What is Robert J. de Vaere Attorney-In-Fact's' Mailing Address?
- Mailing address is Horizon Pharma, Inc. 520 Lake Cook Road, Suite 520 Deerfield IL 60062 IL
Horizon Pharma Plc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Other Earnings Plans or Compensations
|
Total
|
---|---|---|---|---|---|---|---|---|
Timothy P. Walbert | 2020 | $1,146,542 | - | $199,548 | $199,548 | $199,548 | $199,548 | $21,632,803 |
Timothy P. Walbert | 2019 | $1,108,700 | - | $226,871 | $226,871 | $226,871 | $226,871 | $13,873,172 |
Timothy P. Walbert | 2018 | $1,076,250 | - | $160,363 | $160,363 | $160,363 | $160,363 | $16,796,894 |
Paul W. Hoelscher | 2020 | $600,569 | - | $106,485 | $106,485 | $106,485 | $106,485 | $5,915,146 |
Paul W. Hoelscher | 2019 | $580,748 | - | $120,135 | $120,135 | $120,135 | $120,135 | $4,443,588 |
Paul W. Hoelscher | 2018 | $563,750 | - | $104,332 | $104,332 | $104,332 | $104,332 | $7,034,386 |
Andy Pasternak | 2020 | $669,021 | $250,000 | $66,872 | $66,872 | $66,872 | $66,872 | $5,826,126 |
Andy Pasternak | 2019 | $108,333 | $500,000 | $19,188 | $19,188 | $19,188 | $19,188 | $2,924,542 |
Jeffrey W. Sherman, M.D., FACP | 2020 | $578,731 | - | $92,545 | $92,545 | $92,545 | $92,545 | $5,261,300 |
Jeffrey W. Sherman, M.D., FACP | 2019 | $559,630 | - | $95,222 | $95,222 | $95,222 | $95,222 | $3,568,496 |
Jeffrey W. Sherman, M.D., FACP | 2018 | $543,250 | - | $68,263 | $68,263 | $68,263 | $68,263 | $3,678,874 |
Barry J. Moze | 2020 | $628,960 | - | $75,659 | $75,659 | $75,659 | $75,659 | $5,073,877 |
Barry J. Moze | 2019 | $608,201 | - | $58,744 | $58,744 | $58,744 | $58,744 | $4,662,510 |
Barry J. Moze | 2018 | $590,400 | - | $35,114 | $35,114 | $35,114 | $35,114 | $2,732,565 |
No matching records found |
Source: https://www.sec.gov/Archives/edgar/data/1492426/000119312521084225/d42343ddef14a.htm
What are Horizon Pharma Plc's Past Insider Trades?
Horizon Pharma Plc's most recent insider trade came on January 18, 2023 by Andy Pasternak who sold 27,129 units worth $3.07M . In the last 12 years, insiders at Horizon Pharma Plc have sold an estimated value of $967.93M and bought an estimated value of $122.97M worth of shares. Insider trading is most common in January, with the busiest year in 2021. The most active traders at the company are Timothy Walbert, Chairman, Jeffrey Sherman, EVP and Chief Medical Officer, and Paul Hoelscher, EVP .
Horizon Therapeutics Public Ltd Co Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
---|---|---|---|---|---|---|---|
No matching records found |